Novavax said the Food and Drug Administration allowed it to continue testing a combination COVID-19-flu and standalone flu vaccine that had been put on hold.

Novavax is already poised to benefit from a separate combined Covid-flu vaccine via a deal with Sanofi announed earlier this year. Under the $1.4 billion co-licensing agreement, announced in May, ...

The U.S. Food and Drug Administration (FDA) has lifted its hold on a late-stage trial for Novavax’s COVID-influenza combination and standalone flu vaccines, the company reported on Monday ...

The U.S. Food and Drug Administration has lifted its clinical hold on a late-stage trial of Novavax's COVID-influenza and its standalone flu vaccines, the company said on Monday.

(RTTNews) - Novavax, Inc. (NVAX) Monday said the Food and Drug Administration or FDA has removed the clinical hold on its COVID-19-Influenza Combination (CIC) and stand-alone influenza vaccine ...

Based on this, the drug regulator has cleared the company to begin enrollment in the vaccines' planned Phase 3 trial. Novavax (NVAX) will be working with the clinical trial investigators and other ...

Bank of America Securities analyst Alec Stranahan maintained a Buy rating on Revolution Medicines (RVMD – Research Report) today and set ...

On Thursday, Novavax Inc (NVAX) stock saw a modest uptick, ending the day at $9.18 which represents a slight increase of $0.22 or 2.46% from the prior close of $8.96. The stock opened at $9.16 and ...

EMERYVILLE, Calif. (AP) — EMERYVILLE, Calif. (AP) — Dynavax Technologies Corp. (DVAX) on Thursday reported third-quarter net income of $17.6 million. On a per-share basis, the Emeryville, ...

Novavax ends UK COVID-19 vaccine contract, agreeing to repay $123.8M in quarterly installments by 2027 as part of settlement.